Aurora A as a novel therapeutic target for HPV-driven cancers.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1104186

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cervical cancer is caused by a virus and current treatments have not improved for many years. We have performed a screen and identified new drug targets and here we will examine one of these using a drug that has perviously been developed for other cancers. Our preliminary data shows cervical cancer is highly sensitive to this drug and there are few side-effects. We will examine how it works and if it results in permanent protection from new cancers.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $762,328.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cervical cancer | head and neck cancer | inhibitors | papillomavirus infection | therapy

Related Links